Cathay Biotech (SHSE:688065) Institutional Ownership: 9.80% (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688065 Cathay Biotech Inc SHSE:688065
93 GF Score
Price ¥43.16
GF Value ¥49.79
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cathay Biotech Institutional Ownership?

Cathay Biotech SHSE:688065 -0.53% 93 Institutional Ownership is 9.80% as of Aug. 29, 2026. GuruFocus rates SHSE:688065 with a GF Score™ of 93/100 and a GF Value™ of ¥49.79 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cathay Biotech's institutional ownership is 9.80%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cathay Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cathay Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Cathay Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Cathay Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cathay Biotech Institutional Ownership Chart

Cathay Biotech Historical Data

The historical data trend for Cathay Biotech can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 9.71 9.70 10.53 10.53 10.54 9.77 9.77 9.78 9.78 9.80
SHSE:688065
93GF Score
Cathay Biotech Inc SHSE:688065
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cathay Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 9.80% mean?
Cathay Biotech (SHSE:688065) has a Institutional Ownership of 9.80% as of Aug. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cathay Biotech and its competitors.
Is Cathay Biotech's Institutional Ownership too high?
Cathay Biotech's current Institutional Ownership is 9.80%. Overall, Cathay Biotech has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cathay Biotech's Institutional Ownership compare to DOW?
Cathay Biotech's Institutional Ownership of 9.80% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Chemicals company?
A good Institutional Ownership depends on the Chemicals industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cathay Biotech and its competitors. Cathay Biotech's current Institutional Ownership is 9.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cathay Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cathay Biotech (SHSE:688065) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥49.79, compared to a current price of ¥43.16 — trading 13.3% below its estimated fair value. The current Institutional Ownership is 9.80%. Cathay Biotech's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Cathay Biotech (SHSE:688065), the current Institutional Ownership is 9.80% as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cathay Biotech (SHSE:688065) Overvalued in 2026?

Based on GuruFocus' analysis, Cathay Biotech stock appears to be undervalued. The current stock price of ¥43.16 is trading 13.3% below its estimated GF Value™ of ¥49.79. GuruFocus considers Cathay Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688065:

  • Institutional Ownership: 9.80%
  • GF Value™: ¥49.79 vs. price of ¥43.16 (13.3% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688065 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cathay Biotech Business Description

Address Oasis Ring Road, Building 11, Lane 396, Minhang District, Shanghai, CHN, 201114
Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company owns the TERRYL brand, which focuses on bio-based polyamide fibers for textiles, and ECOPENT, which serves the engineering materials market.
93GF Score

Get the complete analysis for SHSE:688065

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥43.16
Price
¥49.79
GF Value